Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide plus monopolar radiofrequency for body contouring in Thai women
TCTR20261007017Phase 4Recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Mar 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in localized adiposity (AL), Overweight, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Mar 2026; status: recruiting.
02
Drugs
03
Conditions
localized adiposity (AL)Overweight
Beyond the preview
Go deeper on TCTR20261007017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261007017.